[Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004576:Electromyography; D005260:Female; D005684:Gait / Q000187:drug effects; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced* / Q000188:drug therapy; D009129:Muscle Tonus / Q000187:drug effects; D010640:Phenothiazines / Q000627:therapeutic use*; D010919:Placebos / Q000494:pharmacology; D011187:Posture / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014268:Trifluoperazine / Q000009:adverse effects; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D010640:Phenothiazines; D010919:Placebos; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D014282:Trihexyphenidyl
Effets de l'éthopropazine et du trihexyphenidyle sur quelques paramètres du syndrome neuroleptique.